TEAR Share Price

Open 0.53 Change Price %
High 0.55 1 Day 0.00 0.00
Low 0.51 1 Week -0.04 -7.02
Close 0.53 1 Month -0.04 -7.02
Volume 139114 1 Year -0.92 -63.45
52 Week High 1.75
52 Week Low 0.51
TEAR Important Levels
Resistance 2 0.57
Resistance 1 0.55
Pivot 0.53
Support 1 0.51
Support 2 0.49
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
DVOX 0.05 -44.44%
More..

TearLab Corporation (NASDAQ: TEAR)

TEAR Technical Analysis 5
As on 2nd Dec 2016 TEAR Share Price closed @ 0.53 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.78 & Strong Sell for SHORT-TERM with Stoploss of 0.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
TEAR Target for December
1st Target up-side 0.63
2nd Target up-side 0.69
3rd Target up-side 0.75
1st Target down-side 0.45
2nd Target down-side 0.39
3rd Target down-side 0.33
TEAR Other Details
Segment EQ
Market Capital 108374600.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.tearlab.com
TEAR Address
TEAR
7360 Carroll Road
Suite 200
San Diego, CA 92121
United States
Interactive Technical Analysis Chart TearLab Corporation ( TEAR NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on TearLab Corporation
TEAR Business Profile
TearLab Corp. is an in-vitro diagnostic company. The Company is commercializing a tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company's first product measures tear film osmolarity for the diagnosis of Dry Eye Disease (DED). TearLab Research, Inc., its wholly owned subsidiary, develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites (i.e. glucose), genes and proteins) at the point-of-care. Commercializing that tear testing platform is the focus of the Company's business. Its TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of three components: the TearLab disposable, the TearLab Pen and the TearLab Reader.